Literature DB >> 28747211

Fluorodeoxyglucose-positron emission tomography/computed tomography imaging features of colloid adenocarcinoma of the lung: a case report.

ZhenGuang Wang1, MingMing Yu2, YueHua Chen3, Yan Kong1.   

Abstract

BACKGROUND: Colloid adenocarcinoma of the lung is a rare subtype of variants of invasive adenocarcinomas. We report the appearance of this unusual entity on 18F-fluorodeoxyglucose positron emission tomography/computed tomography. CASE
PRESENTATION: A 60-year-old man of Chinese Han nationality coughed with a little white sputum for 1 month. Chest computed tomography showed multiple bilateral subpleural nodules and plaques accompanied by air bronchograms, which were most concentrated in the lower lobe of his right lung. Positron emission tomography indicated increased radioactivity uptake with a maximum standardized uptake value of 3.5. Positron emission tomography/computed tomography showed a soft tissue density lesion in his left adrenal gland with a maximum standardized uptake value of 4.1. The positron emission tomography/computed tomography appearance suggested a primary colloid adenocarcinoma in the lower lobe of his right lung accompanied by intrapulmonary and left adrenal gland metastases. The diagnostic rate of colloid adenocarcinoma can be increased by combining the anatomic and metabolic information of lesions.
CONCLUSIONS: The advantage of positron emission tomography/computed tomography in the diagnosis of colloid adenocarcinoma, as with other cancers, is the ability to locate extrapulmonary disease, facilitating clinical staging.

Entities:  

Keywords:  Adenocarcinoma; Computed tomography; Lung neoplasms; Mucinous; Positron emission tomography

Mesh:

Substances:

Year:  2017        PMID: 28747211      PMCID: PMC5530500          DOI: 10.1186/s13256-017-1380-6

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


Background

Colloid adenocarcinoma, a subtype of variants of invasive adenocarcinomas, is characterized histologically by abundant mucus in the tumor [1]. Colloid adenocarcinoma accounts for 0.24% of all lung cancers [2] and has a 5-year survival rate of 51% [3]. Our understanding of colloid adenocarcinoma is insufficient owing to its low incidence in clinical practice. A deeper understanding of the imaging manifestations of colloid adenocarcinoma would be of great significance for the diagnosis and treatment of this disease. A 60-year-old man with colloid adenocarcinoma. Coronal (a) and axial (b) chest computed tomography images showed irregular subpleural nodules and plaques accompanied by air bronchograms that involved the lower lobe of the right lung. Positron emission tomography/computed tomography showed there was slightly increased radioactivity uptake, with maximum standardized uptake value of 3.5 (c). A soft tissue density lesion was found in the left adrenal gland (d) with increased radioactivity uptake and maximum standardized uptake value of 4.1 (e). On histological examination, the tumor was composed predominantly of pools of mucin; hematoxylin and eosin stain, ×400 (f)

Case presentation

A 60-year-old man of Chinese Han nationality coughed with a little white sputum for 1 month. A physical examination showed coarse breath sounds in bilateral lungs with moist rales in the lower lobe of his right lung. The tumor marker cancer antigen 125 (CA-125) was 45.84 U/ml (0 to 35.0) and cytokerantin-19-fragment (CYFRA21-1) was 17.79 ng/ml (0 to 3.3). A chest computed tomography (CT) scan showed multiple plaques and nodules with air bronchograms in bilateral lungs; infectious lesions were suspected. He fasted for at least 6 hours before an intravenous injection of 18F-fluorodeoxyglucose (18F-FDG) at a dose of 0.2 mCi/kg. After resting for 60 minutes, he was given 300 to 500 mL of pure drinking water followed by bladder emptying before a positron emission tomography (PET)/CT examination (Discovery® VCT; GE Healthcare, Milwaukee WI, USA). Before PET scanning, full body CT scanning from his skull base to his mid-femurs was acquired for attenuation correction and anatomic localization with the following scanning parameters: voltage, 120 kV; current, 130 mA; slice thickness, 3.75 mm; and interlayer spacing, 3.27 mm. The PET scanning conditions were as follows: during quiet breathing, the scan time for each bed position was 3 minutes. For the diagnostic chest CT scan, he was trained in breath holding before the examination, and the scan was conducted from his thoracic inlet to the level of his adrenal glands with inspiratory breath hold [4]. Irregular subpleural nodules and plaques accompanied by air bronchograms involved the lower lobe of his right lung (Fig. 1a, b). There was slightly increased radioactivity uptake, with maximum standardized uptake value (SUVmax) of 3.5 (Fig. 1c). Multiple irregular nodules accompanied by air bronchograms involved the subpleural regions of bilateral lungs with slightly increased radioactivity uptake and SUVmax was 1.7. A soft tissue density lesion was found in the left adrenal gland with increased radioactivity uptake and SUVmax was 4.1 (Fig. 1d, e).
Fig. 1

A 60-year-old man with colloid adenocarcinoma. Coronal (a) and axial (b) chest computed tomography images showed irregular subpleural nodules and plaques accompanied by air bronchograms that involved the lower lobe of the right lung. Positron emission tomography/computed tomography showed there was slightly increased radioactivity uptake, with maximum standardized uptake value of 3.5 (c). A soft tissue density lesion was found in the left adrenal gland (d) with increased radioactivity uptake and maximum standardized uptake value of 4.1 (e). On histological examination, the tumor was composed predominantly of pools of mucin; hematoxylin and eosin stain, ×400 (f)

He underwent transthoracic needle biopsy of the lesion of the lower lobe of his right lung. On histological examination, the lesion was composed predominantly of pools of mucin and we suspected colloid adenocarcinoma (Fig. 1f). CDX2, MUC2, CK7, and TTF-1 were positive in this case.

Discussion

Colloid adenocarcinoma originates from columnar epithelial cells or goblet cells, and can secrete a large amount of mucus, resulting in increased mucus in the alveoli [5]. In 2004, Rossi et al. summarized the imaging manifestations of 18 cases of colloid adenocarcinoma, and concluded that the most common imaging manifestation was ill-defined solid peripheral nodules (eight cases) [2]. Other manifestations included consolidation accompanied by air bronchograms and ground-glass opacities (six cases and four cases, respectively) [2]. A study conducted by Sawada et al. also showed solid or partially solid nodules with air bronchograms [6]. The chest CT in this case showed multiple bilateral subpleural nodules and plaques accompanied by air bronchograms, most concentrated in the lower lobe of our patient’s right lung. The potential pathological basis is that the tumor cells grew along the alveolar and bronchial walls and a one-way valve effect caused the alveoli to distend with air, resulting in air bronchograms [7]. The PET in this case showed that the radioactivity uptake of the lesions in our patient’s bilateral lungs and his left adrenal gland was slightly increased with SUVmax of 3.5 and 4.1, respectively. We suspected colloid adenocarcinoma in the lower lobe of his right lung with intrapulmonary and left adrenal gland metastases. The radioactivity uptake of colloid adenocarcinoma was relatively lower. This may be due in part to: (1) large amounts of mucus in the tumor; (2) and the metabolism of slow-growing tumors is generally low [8]. Colloid adenocarcinoma has a higher frequency of metastasis than other types of lung cancer, including intrapulmonary metastasis, hematogenous metastasis, and lymphatic metastasis [9]. Studies have shown that colloid adenocarcinoma tends to spread along the airway mucosa and results in intrapulmonary metastases [10]. A follow-up study conducted by Oka et al. for 13 cases of colloid adenocarcinoma confirmed after surgery or biopsy indicated that primary tumors with diameters ≤3 cm had a better prognosis, while larger tumors tended to recur and develop intrapulmonary metastases [11]. This case indicated that the colloid adenocarcinoma from the lower lobe of our patient’s right lung metastasized to bilateral lungs and his left adrenal gland. PET/CT combined with the diagnostic chest CT were valuable for diagnosis and staging of colloid adenocarcinoma although colloid adenocarcinoma had a relatively lower FDG uptake.

Conclusions

Proper staging is of significant value for the evaluation of patient prognosis as well as the selection of treatment protocols. PET/CT combined with a diagnostic chest CT were valuable for diagnosis and staging of colloid adenocarcinoma although the colloid adenocarcinoma had a relative lower FDG uptake.
  11 in total

1.  Lobar mucinous bronchioloalveolar carcinoma of the lung showing negative FDG uptake on integrated PET/CT.

Authors:  Yon Mi Sung; Kyung Soo Lee; Byung-Tae Kim; Joungho Han; Eun Jeong Lee
Journal:  Eur Radiol       Date:  2005-02-17       Impact factor: 5.315

2.  Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.

Authors:  Prudence A Russell; Zoe Wainer; Gavin M Wright; Marissa Daniels; Matthew Conron; Richard A Williams
Journal:  J Thorac Oncol       Date:  2011-09       Impact factor: 15.609

3.  Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlates.

Authors:  F Clayton
Journal:  Cancer       Date:  1986-04-15       Impact factor: 6.860

4.  Mucin-producing adenocarcinoma of the lung: thin-section computed tomography findings in 48 patients and their effect on prognosis.

Authors:  Ukihide Tateishi; Nestor L Müller; Takeshi Johkoh; Arafumi Maeshima; Hisao Asamura; Mitsuo Satake; Masahiko Kusumoto; Yasuaki Arai
Journal:  J Comput Assist Tomogr       Date:  2005 May-Jun       Impact factor: 1.826

5.  Localized mucinous bronchioloalveolar carcinoma of the lung: thin-section computed tomography and fluorodeoxyglucose positron emission tomography findings.

Authors:  Eiichi Sawada; Atsushi Nambu; Utaroh Motosugi; Tsutomu Araki; Satoshi Kato; Yoko Sato; Akitoshi Saito; Hiroshi Ishihara; Hideto Okuwaki; Katsura Ozawa; Keiichi Nishikawa; Masahisa Miyazawa; Kazuyuki Miyata
Journal:  Jpn J Radiol       Date:  2010-05-29       Impact factor: 2.374

6.  Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression.

Authors:  Giulio Rossi; Bruno Murer; Alberto Cavazza; Lorena Losi; Pamela Natali; Alessandro Marchioni; Mario Migaldi; Giovanni Capitanio; Elisabeth Brambilla
Journal:  Am J Surg Pathol       Date:  2004-04       Impact factor: 6.394

7.  Ground-glass opacities on thin-section helical CT: differentiation between bronchioloalveolar carcinoma and atypical adenomatous hyperplasia.

Authors:  Seitaro Oda; Kazuo Awai; Duo Liu; Takeshi Nakaura; Yumi Yanaga; Hiroaki Nomori; Yasuyuki Yamashita
Journal:  AJR Am J Roentgenol       Date:  2008-05       Impact factor: 3.959

8.  Surgical resection for patients with mucinous bronchioloalveolar carcinoma.

Authors:  Souichi Oka; Takeshi Hanagiri; Hidetaka Uramoto; Tetsuro Baba; Masaru Takenaka; Manabu Yasuda; Kenji Ono; Tomoko So; Mitsuhiro Takenoyama; Kosei Yasumoto
Journal:  Asian J Surg       Date:  2010-04       Impact factor: 2.767

9.  Patterns of recurrence of bronchioloalveolar cell carcinoma after surgical resection: a radiological, histological, and immunohistochemical study.

Authors:  Michele Gaeta; Alfredo Blandino; Stefano Pergolizzi; Silvio Mazziotti; Rosario Caruso; Mario Barone; Stefano Cascinu
Journal:  Lung Cancer       Date:  2003-12       Impact factor: 5.705

10.  The applications of corrected standardized uptake values in the diagnosis of peripheral lung lesions.

Authors:  Ming Ming; Zhen G Wang; DaCheng Li; FengYu Wu; SiMin Liu; Bin Shi; Wei Xue
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.